Patents by Inventor Waclaw Rzeszotarski

Waclaw Rzeszotarski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Corticotropin-releasing factor antagonism compounds
    Patent number: 5063245
    Abstract: The present invention relates to a method of producing corticotropin-releasing factor (CRF) antagonist activity and thus provides a method of treating a wide range of stress-related disorders, including affective illnesses, such as depression and anxiety, as well as irritable bowel syndrome, anorexia nervosa, cardiovascular abnormalities and stress-induced immune suppression. The invention also relates to compounds (4-substituted thio-5-oxo-3-pyrazolines) and to pharmaceutical compositions suitable for use in such a method.
    Type: Grant
    Filed: March 28, 1990
    Date of Patent: November 5, 1991
    Assignee: Nova Pharmaceutical Corporation
    Inventors: Mary E. Abreu, Waclaw Rzeszotarski, Donald J. Kyle, Roger N. Hiner, Richard L. Elliott